4th Global Congress on Sickle Cell Disease
The 4th Global Congress on Sickle Cell Disease will convene in Paris on June 16-18, 2022. Partners of the Club du Globule Rouge et du Fer, the French Society of Hematology, the European Hematology Association, and the University of Paris.
Sickle cell disease is one the world’s most prevalent genetic diseases. Major advances have been made in understanding the disease, paving the way for new and effective treatments. Neonatal screening is developing in many countries, resulting in early prevention of infections and improved parental education. New preventive treatments for vaso-occlusive crises and chronic anaemia are now available.
We are pleased to invite you to visit our booth #05 and learn more about our HemoTypeSC™ universal screening for sickle cell disease and sickle cell trait.